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Background: Integrins induce the formation of large complexes of cytoskeletal
and signaling proteins, which regulate many intracellular processes. The
activation and assembly of signaling complexes involving focal adhesion kinase
(FAK) occurs late in integrin signaling, downstream from actin polymerization.
Our previous studies indicated that integrin-mediated activation of the non-
receptor tyrosine kinase Syk in hematopoietic cells is independent of FAK and
actin polymerization, and suggested the existence of a distinct signaling
pathway regulated by Syk.
Results: Multiple proteins were found to be activated by Syk, downstream of
engagement of the platelet/megakaryocyte-specific integrin αIIbβ3. The guanine
nucleotide exchange factor Vav1 was inducibly phosphorylated in a Syk-
dependent manner in cells following their attachment to fibrinogen. Together,
Syk and Vav1 triggered lamellipodia formation in fibrinogen-adherent cells and
both Syk and Vav1 colocalized with αIIbβ3 in lamellipodia but not in focal
adhesions. Additionally, Syk and Vav1 cooperatively induced activation of Jun
N-terminal kinase (JNK), extracellular-signal-regulated kinase 2 (ERK2) and the
kinase Akt, and phosphorylation of the oncoprotein Cbl in fibrinogen-adherent
cells. Activation of all of these proteins by Syk and Vav1 was not dependent on
actin polymerization.
Conclusions: Syk and Vav1 regulate a unique integrin signaling pathway that
differs from the FAK pathway in its proximity to the integrin itself, its localization
to lamellipodia, and its activation, which is independent of actin polymerization.
This pathway may regulate multiple downstream events in hematopoietic cells,
including Rac-induced lamellipodia formation, tyrosine phosphorylation of Cbl,
and activation of JNK, ERK2 and the phosphatidylinositol 3′-kinase-regulated
kinase Akt.
Background
Integrins are heterodimeric receptors that mediate
cell–matrix and cell–cell adhesion. Following ligand
engagement, the cytoplasmic domains of integrins associ-
ate with multiple intracellular protein complexes to form
large protein networks. These networks of cytoskeletal and
signaling proteins stabilize cell adhesion, induce alterations
in cell shape and movement, and transduce signals that
regulate cell proliferation, survival and differentiation [1,2].
The dissection of these protein networks to delineate sig-
naling pathways responsible for specific integrin-induced
events represents a significant challenge in this area.
The best characterized signaling complex activated by inte-
grins involves the focal adhesion kinase (FAK). This protein
localizes to focal adhesion sites, functions as a protein tyro-
sine kinase, and serves as a scaffold protein that binds to
multiple cytoskeletal and signaling proteins, including inte-
grins, talin, paxillin, Src kinases, phosphatidylinositol (PI)
3′-kinase, Cas, Graf and Grb2 [2]. FAK regulates pathways
that control cell migration, growth and survival through
activation of extracellular-signal-regulated kinases (ERKs)
of the mitogen-activated protein (MAP) kinase family, 
PI 3′-kinase and multiple small GTPases. The activation
of FAK and organization of FAK complexes is inhibited
by cytochalasin D, which prevents actin polymerization
following integrin engagement. These results suggest that
pathways regulated by FAK are activated at a relatively
late stage of integrin signaling, downstream from events
that regulate actin polymerization. 
Studies of the integrin αIIbβ3 in platelets and in a recon-
stituted model system in chinese hamster ovary (CHO)
cells have provided evidence for the existence of a distinct
integrin-regulated pathway involving a hematopoietic-
cell-specific protein tyrosine kinase, Syk. Syk activation in
response to fibrinogen binding to αIIbβ3 is not inhibited
by cytochalasin D and can be induced by experimental
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dimerization of αIIbβ3, even in the absence of fibrinogen
binding [3–6]. Moreover, unlike FAK activation, Syk acti-
vation requires the activity of one or more Src family
kinases and the presence of both the αIIb and β3 cyto-
plasmic tails [5]. Consequently, the activation of Syk may
represent an event more proximal to αIIbβ3 engagement,
and independent of FAK. Furthermore, the studies in
CHO cells have recapitulated many of the features of
‘outside–in’ signaling typical of platelets, most notably
the relative time courses of Syk and FAK tyrosine phos-
phorylation after cell adhesion to fibrinogen, and the dif-
ferent sensitivities of these two tyrosine kinases to
cytochalasin D [5].
On the basis of these considerations, we reasoned that the
CHO cell model system might be useful in characterizing
events downstream of Syk activation in an integrin signal-
ing pathway. Therefore, we transiently expressed Syk and
other relevant signaling molecules in the A5 CHO cell
line, which stably expresses αIIbβ3, and evaluated the
morphological and biochemical consequences during cell
adhesion to fibrinogen. The results define a previously
uncharacterized pathway downstream of Syk and the
guanine nucleotide exchange factor Vav1 that regulates
multiple membrane-proximal signaling events and
lamellipodia formation.
Results
Integrin aIIbb3 and Syk cooperate to stimulate tyrosine
phosphorylation of Vav1
Syk becomes tyrosine phosphorylated and activated
during integrin-dependent adhesion of hematopoietic
cells [3,4,7–9]. To better define the role of Syk in
outside–in signaling through αIIbβ3, we studied the adhe-
sive and signaling responses of A5 CHO cells stably
expressing αIIbβ3 after transient transfection of Syk and
other potentially relevant signaling molecules. As the
expression of αIIbβ3 and Syk is restricted to hemato-
poietic cells, we reasoned that some of their downstream
effectors might be similarly restricted. One such candidate
effector is Vav1, a hematopoietic-specific Rho family
guanine nucleotide exchange factor, which can couple
with Syk and multiple downstream effectors [10,11] and is
tyrosine phosphorylated in integrin-stimulated myeloid
cells, neutrophils and platelets [8,12,13].
To examine whether αIIbβ3 induces tyrosine phosphoryl-
ation of Vav1 in a Syk-dependent manner, A5 CHO cells
transiently expressing Syk and/or Vav1 were placed in sus-
pension or plated onto fibrinogen-coated dishes. After
30 minutes, tyrosine phosphorylation of Syk and Vav1 was
assessed on immunoblots. As reported previously [5], 
fibrinogen-adherent cells transfected with Syk exhibited
prominent tyrosine phosphorylation of Syk, whereas the
same cells maintained in suspension did not (Figure 1). In
contrast, when Vav1 was expressed alone, it failed to
become tyrosine-phosphorylated. When Vav1 was co-
expressed with Syk, however, there was slight tyrosine
phosphorylation of Vav1 in suspended cells but promi-
nent tyrosine phosphorylation of Vav1 in adherent cells.
The amounts of Syk and Vav1 recovered in the immuno-
precipitates of suspended and adherent cells were
similar, confirming that cell adhesion had increased the
levels of tyrosine phosphorylation of these proteins
(Figure 1). The phosphorylation response of Vav1 paral-
leled that of Syk over time — responses to adhesion were
already maximal by 15 minutes, the earliest time point
studied, and persisted for at least 45 minutes (data not
shown). These results establish that Vav1 can become
tyrosine phosphorylated in response to cell adhesion
mediated by αIIbβ3, but only under conditions in which
Syk is also expressed.
Integrin-induced tyrosine phosphorylation of Syk is asso-
ciated with increased Syk kinase activity [3,5,9]. To evalu-
ate whether Syk kinase activity was required for
integrin-dependent phosphorylation of Vav1, the experi-
ments above were repeated using a kinase-inactive form
of Syk (lysine 402 residue mutated to arginine; K402R). In
contrast to the results with wild-type Syk, no tyrosine
phosphorylation of Syk K402R or Vav1 was observed
during A5 CHO cell adhesion to fibrinogen, despite levels
of expression of Syk K402R similar to those of wild-type
Syk (Figure 1). Thus, integrin-dependent tyrosine phos-
phorylation of Vav1 requires Syk catalytic function.
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Figure 1
Syk-dependent regulation of Vav1 through αIIbβ3. A5 CHO cells were
transfected with Vav1 alone or along with wild-type (WT) or the K402R
mutant of Syk. The ability of Syk and Vav1 to be inducibly tyrosine
phosphorylated after plating on fibrinogen (FBGN) for 30 min was
measured by immunoblotting with anti-phosphotyrosine antibody (pTyr
blot) following immunoprecipitation (IP) with the corresponding
antibody. Levels of total Syk and Vav1 in the immunoprecipitates were
measured by immunoblotting with appropriate antibody.
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Vav1 blot: –Vav1
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Src family kinases are activated following platelet stimula-
tion [14], and the ability of Syk to be activated in
fibrinogen-adherent A5 CHO cells requires Src activation
[5]. Inhibition of endogenous Src kinases by transient
expression of a kinase-inactive, dominant-negative Src
mutant (lysine 295 residue mutated to arginine; K295R)
greatly reduced adhesion-dependent tyrosine phosphory-
lation of both Syk and Vav1 (data not shown). Thus, one
or more Src family kinases are required for Vav1 tyrosine
phosphorylation, possibly through Src activation of Syk.
Integrin aIIbb3, Syk and Vav1 signal to Rac
Tyrosine phosphorylation of Vav1 has been shown to lead
to an increase in its guanine nucleotide exchange activity
toward Rho family GTPases, particularly Rac [10]. Two
prominent responses to activated Rac in adherent cells are
lamellipodia formation [15] and activation of Jun N-termi-
nal kinase (JNK) [16]. To address whether Syk and/or
Vav1 expression enhances lamellipodia formation follow-
ing αIIbβ3 engagement, A5 CHO cells were transfected
with Syk, Vav1 and green fluorescent protein (GFP, as a
marker for transfection) and plated on fibrinogen-coated
coverslips. Adherent cells were fixed, stained with 
rhodamine–phalloidin to mark filamentous actin (F-actin)
and studied by confocal microscopy. Cell attachment to
the coverslips was entirely dependent on αIIbβ3 because
it was prevented by preincubation of cells with a function-
blocking anti-αIIbβ3 antibody (A2A9, 10 µg/ml) or by an
αIIbβ3-selective cyclic peptide (integrilin, 10 µM). 
Following attachment to fibrinogen, there was progressive
cell spreading, lamellipodia extension and focal adhesion
formation. Lamellipodia were identified by their character-
istic appearance on the ventral surface of the cells and by
positive membrane-proximal staining in these locations for
αIIbβ3 and F-actin (Figure 2). Expression of Syk and Vav1
caused a dramatic increase in lamellipodia formation. Of
the cells transfected with GFP, Syk and Vav1, 52% exhib-
ited one or more lamellipodia and many cells contained
several of these structures (Figure 2). In contrast, only a
minority of untransfected (GFP-negative) cells on the same
coverslip exhibited lamellipodia. Only 15% of control cells
transfected with GFP alone or with GFP and Syk (but not
Vav1) displayed lamellipodia, and the difference between
these cells and the GFP+Syk+Vav1 transfectants was statis-
tically significant (p < 0.0001). In the case of cells express-
ing GFP and Vav1 (but not Syk), 22% contained one or
more lamellipodia; this was significantly greater than that
seen with GFP or GFP+Syk transfectants but significantly
less than that observed with GFP+Syk+Vav1 transfectants
(p < 0.0001). Cotransfection with Syk, Vav1 and a domi-
nant-inhibitory form of Rac, RacN17, reduced lamellipodia
formation to levels below that of untransfected cells (data
not shown), indicating that Rac or a closely related small
GTPase is required for Syk and Vav1 enhancement of
lamellipodia formation in fibrinogen-adherent cells.
After 18 hours of adhesion on fibrinogen, Syk transfectants
exhibited Syk staining throughout the cell. Nonetheless, in
most cells, Syk frequently colocalized with αIIbβ3 and F-
actin along the membranes of lamellipodia. Similar results
were obtained with cells plated on fibrinogen for only
15 minutes (Figure 3a–c). In Vav1 transfectants, Vav1 was
also present throughout the cell, but colocalization with
αIIbβ3 or F-actin was much less apparent and observed
only in an occasional lamellipodium in a minority of the
cells (Figure 3e–g). In addition to lamellipodia, most
Syk/Vav1 transfectants also contained numerous focal
adhesions that stained with an antibody to αIIbβ3 and
were connected to actin stress fibers that stained with rho-
damine–phalloidin. No Syk or Vav1 was observed in these
structures, however (Figure 3d,h). These results indicate
that A5 CHO cell adhesion through αIIbβ3 triggers lamel-
lipodia formation in a manner that is dependent on Syk
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Figure 2
Effect of Syk and Vav1 on lamellipodia formation in fibrinogen-adherent
A5 CHO cells. Cells were transfected with GFP alone (bottom panel)
or with a combination of GFP, Syk and Vav1 (top and middle panels);
24 h later, the cells were plated onto fibrinogen-coated coverslips and
incubated for 18 h. Adherent cells were fixed, permeabilized and
stained with rhodamine–phalloidin to mark F-actin, and studied by
confocal microscopy. Positive green fluorescence of cells due to
expression of GFP was taken as an indication of successful
transfection. Cells subjected to the transfection procedure with GFP,
Syk and Vav1 but which failed to express GFP (middle panel) were
taken as ‘untransfected’ cells. The cells shown in each panel are
representative of predominant morphologies from all five experiments
so performed. Bar = 10 µm.
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and Vav1, consistent with the hypothesis that tyrosine-
phosphorylated Vav1 participates in the activation of Rac
but does not function within focal adhesions.
To determine whether Syk and Vav1 regulate JNK activa-
tion through Rac, A5 CHO cells were transiently trans-
fected with hemagglutinin (HA) epitope-tagged JNK,
plated on fibrinogen for 45 minutes, and the enzymatic
activity in JNK immunoprecipitates was assessed using a
glutathione S-transferase (GST)–c-Jun fusion protein as a
substrate. Fibrinogen-adherent cells cotransfected with Syk
and Vav1 exhibited a significant increase in JNK activity
(7.5 ± 2.6-fold, p < 0.005). No increase was observed in cells
transfected with Syk alone, and a modest increase was seen
with Vav1 alone (2.9 ± 0.9-fold; Figure 4a). JNK activation
was reduced 66% by coexpression of dominant-negative
RacN17 (Figure 4b). Taken together, these results indicate
that Rac can serve as a downstream effector of αIIbβ3 in a
pathway that includes Src, Syk and Vav1. 
Integrin aIIbb3, Syk and Vav1 signal to ERK2
The ERKs are activated following engagement of integrins
in many cell types [2,17]. Whereas the best defined integrin
pathways leading to activation of ERK involve Src kinases
in association with either FAK or caveolin [18,19], Syk has
been shown to regulate ERK activation in other receptor
pathways [20,21]. The constitutive association of Vav1 with
Grb2 and other components of the ERK pathway [22] sug-
gests that Vav1 can contribute to activation of ERK in
hematopoietic cells. Therefore, we studied the effect of A5
CHO cell adhesion to fibrinogen on the activity of 
HA-tagged ERK2, using myelin basic protein as a substrate.
In cells transfected with ERK2, Syk and Vav1, cell adhe-
sion to fibrinogen increased ERK2 activity 4 ± 0.9-fold. Syk
alone did not enhance ERK2 activity, whereas Vav1 slightly
increased ERK2 activation (2 ± 0.5-fold; Figure 5a). Unlike
JNK, however, ERK2 activation was not blocked by expres-
sion of dominant-negative RacN17 (data not shown), but
was blocked by expression of dominant-negative RasN17
(Figure 5b). Thus, αIIbβ3, Syk and Vav1 can collaborate to
activate both ERK2 and JNK, albeit by routes which differ
in their dependency on Rac.
Integrin aIIbb3, Syk and Vav1 signal to c-Cbl
Cbl is a multi-domain protein that associates with many
other cellular proteins through its Src homology 2 (SH2)-
domain-like phosphotyrosine-binding domain, proline-rich
SH3-domain-binding motifs and tyrosine-phosphorylated
SH2-binding sites [23]. We were interested in whether Syk
and Vav1 might couple with Cbl downstream of αIIbβ3 as
Cbl is phosphorylated on tyrosine following engagement of
integrins, and associates with Syk and Vav1 in activated T
lymphocytes [24–26]. Cbl also associates with the p85
subunit of PI 3′-kinase, raising the possibility that Cbl
could couple Syk and αIIbβ3 to PI 3′-kinase activity [27].
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Figure 3
Partial colocalization of Syk and Vav1 with αIIbβ3 and F-actin in the
lamellipodia of fibrinogen-adherent A5 CHO cells. (a–d) Cells were
transfected with Syk and plated 24 h later onto fibrinogen-coated
coverslips for either (a,c) 15 min or (b,d) 18 h. Cells were double-
stained with an antibody to Syk (green, a–d), and
rhodamine–phalloidin (red; a,b) or an antibody to αIIb (red; c,d).
Lamellipodia are present in (a–c) and yellow areas representing
colocalization of Syk and F-actin, or Syk and αIIb, can be observed at
the periphery of these structures (arrowheads). In contrast, the cell in
(d) exhibits many red, integrin-rich focal adhesions and there is no Syk
colocalization to focal adhesions. (e–h) Cells were transfected with
Syk and Vav1 and plated for 18 h onto fibrinogen-coated coverslips.
The cells were double-stained with antibodies to the Myc epitope tag
of Vav1 (green) and to αIIb (red). Occasional areas of colocalization of
αIIb and Vav1 can be seen (yellow, arrowheads). (h) Vav1 does not
colocalize to focal adhesions (red). Bars = 10 µm. These results are
representative of three separate experiments.
To examine Cbl phosphorylation and its association with
p85, HA-tagged c-Cbl was transiently expressed in A5
CHO cells. The adhesion of these cells to fibrinogen
resulted in a Syk-dependent increase in tyrosine phospho-
rylation of Cbl and this response was dramatically
enhanced by the combination of Syk and Vav1 (Figure 6).
Furthermore, p85 could be selectively recovered in Cbl
immunoprecipitates from fibrinogen-adherent cells that
expressed both Syk and Vav1 (Figure 6). Thus, an
αIIbβ3–Syk–Vav1 pathway may promote assembly of a
multimolecular signaling complex that includes Cbl and
the activated p85 subunit of PI 3′-kinase.
Integrin aIIbb3, Syk and Vav1 signal to PI 3¢-kinase
The activity of endogenous PI 3′-kinase was studied indi-
rectly by determining the activity of an HA-tagged PI 
3′-kinase effector, Akt, using histone 2B as a substrate.
Akt is a serine/threonine kinase that is dependent on PI
3′-kinase for activation following integrin stimulation
[28,29]. Adhesion of A5 CHO cells to fibrinogen induced a
2 ± 0.5-fold increase in Akt activity in a manner that was
dependent on both Syk and Vav1 expression (Figure 7a).
This response was not inhibited by coexpression of 
dominant-negative RacN17, but was blocked by domi-
nant-negative Ras (data not shown). Akt activation was
also inhibited by pretreatment of the cells with 100 nM
wortmannin, a PI 3′-kinase inhibitor, consistent with the
idea that Syk and Vav1 enhancement of Akt activation was
mediated through activation of PI 3′-kinase (Figure 7b).
As PI 3′-kinase has been implicated in numerous post-
ligand binding events during outside–in integrin signaling
in platelets [29,30], the effect of 100 nM wortmannin on
other Syk-dependent and Vav1-dependent responses in
fibrinogen-adherent A5 CHO cells was studied. In two
experiments, wortmannin decreased the percentage of
control-GFP-transfected cells that have lamellipodia from
an average of 14.3% to 8.0%, whereas it decreased the
ability of Syk and Vav1 to induce lamellipodia formation
from 52.3% to 20.5%. Wortmannin also blocked the ability
of Syk and Vav1 to enhance adhesion-dependent Akt acti-
vation (Figure 7b), but it had no effect on their ability to
enhance JNK or ERK2 activation (data not shown). 
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Figure 4
Effects of Syk and Vav1 on JNK activity in A5 CHO cells. (a) Cells
were transfected with Syk, Vav1 and HA-tagged JNK in the indicated
combinations; a dash indicates cells that were not transfected. After
48 h, cells were placed in suspension on bovine serum albumin (BSA)-
coated plates, or plated on fibrinogen (FBGN) for 45 min, and the
levels of JNK kinase activity were measured in HA–JNK
immunoprecipitates using GST–c-Jun as the substrate. Total levels of
JNK in the kinase assay were monitored by immunoblotting with anti-
JNK antibody (JNK blot). (b) A dominant-negative mutant of Rac
(RacN17) was cotransfected with Syk, Vav1 and HA–JNK and its
effect on JNK kinase activity measured as described in (a).
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Figure 5
Effect of Syk and Vav1 on ERK2 activity in A5 CHO cells. (a) Cells
were transfected with Syk, Vav1 and HA-tagged ERK2 in the indicated
combinations. After 48 h, cells were left in suspension or plated on
fibrinogen (FBGN) for 45 min and the levels of ERK2 kinase activity
were measured in HA–ERK2 immunoprecipitates using myelin basic
protein (MBP) as a substrate. Total levels of ERK2 in the kinase assay
were measured by immunoblotting with anti-ERK antibody (ERK blot).
(b) A dominant-negative mutant of Ras (RasN17) was cotransfected
with Syk, Vav1 and HA-tagged ERK2 and its effect on ERK2 activity
was measured as in (a).
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Integrin-αIIbβ3-mediated tyrosine phosphorylation of Syk,
Vav1 and Cbl were also unaffected by wortmannin (data
not shown). Taken together, these data indicate that acti-
vation of PI 3′-kinase is required for Rac-mediated lamelli-
podia formation downstream of Syk and Vav1, but it is not
required for other events regulated by these proteins.
Sensitivity of Syk-regulated and Vav1-regulated events to
inhibition of actin polymerization
Assembly and reorganization of the actin cytoskeleton are
required for many biological responses of cells to integrin-
mediated adhesion [31,32]. Tyrosine phosphorylation of
Syk in fibronectin-adherent monocytes or fibrinogen-adher-
ent A5 CHO cells is not sensitive to cytochalasin D, an
inhibitor of actin polymerization [5,7]. Similarly, cytocha-
lasin D failed to inhibit either tyrosine phosphorylation of
Vav1 in fibrinogen-adherent A5 CHO cells (Figure 8a) or
the ability of Src to enhance Syk and Vav1 tyrosine phos-
phorylation (data not shown). These results are consistent
with the idea that Src, Syk and Vav1 activation are proximal
events in αIIbβ3 signaling that require neither actin poly-
merization nor cytoskeletal reorganization.
Cytochalasin D also failed to inhibit several other Syk and
Vav1 responses in fibrinogen-adherent cells, including Cbl
tyrosine phosphorylation and association with p85
(Figure 8a), and activation of JNK, ERK2 and Akt
(Figure 8b). Yet in these same experiments, cytochalasin
D fully inhibited adhesion-dependent FAK tyrosine
phosphorylation (Figure 8c) and cell spreading (data not
shown). Together these data suggest that Syk and Vav1
assemble a signaling complex downstream of αIIbβ3 that
is independent of actin polymerization and distinct from
the FAK pathway. 
Discussion
The present studies were carried out to identify and 
characterize signaling pathways and cellular responses trig-
gered by platelet integrin αIIbβ3 and propagated through
the hematopoietic-cell-specific tyrosine kinase Syk. The
major conclusions are as follows. First, adhesion of αIIbβ3-
expressing A5 CHO cells to fibrinogen triggers a series of
responses that are dependent on kinase-active Syk and
Vav1. Second, these responses include lamellipodia forma-
tion, activation of the MAP kinases ERK2 and JNK, and PI
3′-kinase, and tyrosine phosphorylation of Cbl. Third, all of
the biochemical responses occurred in the presence of
cytochalasin D, indicating that they are independent of
actin polymerization and distinct from signaling pathways
involving FAK. Fourth, one major effector in the
αIIbβ3–Syk–Vav1 pathway is Rac, which mediates lamelli-
podia formation and JNK activation. Other effectors must
be involved, however, as Vav1-dependent activation of
ERK2 and PI 3′-kinase was independent of Rac. Fifth,
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Figure 7
Effect of Syk and Vav1 on Akt activity in A5 CHO cells. (a) Cells were
transfected with Syk, Vav1 and HA-tagged Akt. After 48 h, cells were
maintained in suspension or plated on fibrinogen (FBGN) for 45 min
and the levels of Akt kinase activity were measured in HA–Akt
immunoprecipitates using histone 2B (H2B) as a substrate.
Preimmune serum (PS) was added as a control. Total levels of Akt in
the kinase assay were measured by immunoblotting with anti-Akt
antibody (Akt blot). (b) The level of PI 3′-kinase-dependent activation
of HA–Akt was monitored by inhibition with 100 nM wortmannin.
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Figure 6
Syk and Vav1 regulate Cbl phosphorylation and association with
PI 3′-kinase. A5 CHO cells were transfected with Syk, Vav1 and 
HA-tagged Cbl. After 48 h, the levels of tyrosine phosphorylation of
Cbl after plating on fibrinogen (FBGN) for 45 min were monitored by
immunoblotting with anti-phosphotyrosine antibody (pTyr blot)
following immunoprecipitation (IP) with anti-Cbl antibody. The ability of
the p85 subunit of PI 3′-kinase to associate with Cbl was detected by
immunoblotting the Cbl immunoprecipitates with anti-p85 antibody
(p85 blot). Total levels of Cbl in the IP were measured by
immunoblotting with anti-Cbl antibody (Cbl blot).
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colocalization and coprecipitation studies indicated that
Syk and Vav1 may regulate the assembly of an integrin-
proximal, multimolecular signaling complex that would be
unique to platelets and possibly other hematopoietic cells.
These conclusions were derived from studies in a CHO
cell model system but are likely to be directly relevant to
αIIbβ3 signaling in platelets. As in A5 CHO cells, Syk and
Vav1 become phosphorylated on tyrosine residues when
platelets adhere to fibrinogen [3,12]. Induction of
phosphorylation in both cell types is rapid, consistent with
a role for Syk and Vav1 during initial events triggered by
platelet adhesion, such as actin polymerization and lamelli-
podial extension [30,33]. Furthermore, just as in CHO
cells, integrin-dependent activation of Syk in hemato-
poietic cells is not prevented by cytochalasin D, whereas
FAK activation is [7].
The enhanced activation of multiple signaling pathways
by Syk and Vav1 does not appear to be the consequence
of a non-specific increase in all αIIbβ3-induced signaling
events as αIIbβ3-dependent FAK and SHPS-1 [34]
phosphorylation is not enhanced by Syk and Vav1 expres-
sion (data not shown). Furthermore, each of the signaling
pathways activated by Syk and Vav1 coexpression are dif-
ferentially regulated by distinct subsets of downstream
signals. For example, Rac is specifically required for JNK
activation, but not for ERK2 or Akt activation, whereas PI
3′-kinase is required for Akt activation and lamellipodia
formation, but not for JNK or ERK2 activation. Thus, the
strong parallels between platelets and the reconstituted
CHO cell system and the specificity of the effects indicate
that the A5 CHO cells provide a means to dissect the
potential role of Syk and Vav1 in integrin signaling that is
not possible with human platelets.
Integrin signaling to Vav1
The rapid and marked increase in tyrosine phosphoryl-
ation of Vav1 in fibrinogen-adherent A5 CHO cells
required coexpression and tyrosine phosphorylation of Syk
and Vav1, and the kinase activity of Syk. This suggests
that Vav1 phosphorylation may be mediated directly by
Syk, an idea consistent with the following observations:
first, adhesion of A5 CHO cells and platelets to fibrinogen
increases Syk kinase activity [3,5]; second, a dominant-
negative form of Src, which inhibits Syk activation in A5
cells [5], also inhibited Vav1 phosphorylation; and, third,
Syk and Vav1 are capable of a binary interaction involving
the SH2 domain of Vav1 and tyrosine residues within the
linker region of Syk [11].
In addition to platelets, neutrophils and hematopoietic
cell lines exhibit tyrosine phosphorylation of Syk and
Vav1 following engagement of β1 or β2 integrins [7–9,13].
The existence of an integrin pathway with at least two
components specific to hematopoietic cells suggests that it
might promote specialized adhesive functions, including
hematopoietic cell development, platelet spreading on
vascular matrices, or leukocyte migration across the
endothelium. It remains to be determined, however,
whether an integrin–Syk–Vav1 pathway is essential for a
subset of integrin-dependent responses in hematopoietic
cells or whether it plays an adjunctive role. For example,
Rac figures prominently in the αIIbβ3–Syk–Vav1
pathway. On the other hand, integrins can facilitate the
activation of Rac in non-hematopoietic cells in the
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Figure 8
Syk and Vav1 activate downstream signals
independent of actin polymerization. A5 CHO
cells were transfected with Syk and Vav1
along with (a) HA–Cbl, (b) HA–JNK,
HA–ERK2, or HA–Akt. Cells were plated on
fibrinogen (FBGN) in the absence or
presence of cytochalasin D (CytoD), and the
levels of (a) Syk, Vav1 and Cbl
phosphorylation and association with the p85
subunit of PI 3′-kinase, or (b) JNK, ERK2, and
Akt kinase activity were measured as
described in Figures 1, 4–7. Total levels of
each protein in the immunoprecipitates were
measured by immunoblotting with the
appropriate antibody. (c) FAK
immunoprecipitates (IP) were immunoblotted
with anti-phosphotyrosine antibody (pTyr blot)
to monitor levels of FAK phosphorylation.
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absence of Syk and Vav1 [35], and receptors other than
integrins may activate Rac in hematopoietic cells.
Integrin aIIbb3 signaling to Rac 
Studies in fibroblasts and other cells have established that
integrins collaborate with growth factor, cytokine and 
G-protein-linked receptors to effect a sequence of actin-
driven events at the cell periphery, including the forma-
tion of filopodia, lamellipodia and focal adhesions. These
responses are mediated, in part, by Cdc42, Rac and Rho,
respectively [36,37]. What is the relationship of integrin
signaling to these small GTPases?
The present studies provide support for the idea that
αIIbβ3 may signal to Rac. First, Syk, and to a lesser extent
Vav1, localized with αIIbβ3 and F-actin at the periphery of
lamellipodia, but neither Syk nor Vav1 were ever observed
within focal adhesions. Second, filopodia were not promi-
nent in A5 CHO cells in these experiments, but when Syk
and Vav1 were coexpressed, these cells exhibited a marked
increase in lamellipodia formation. Third, the adhesion of
A5 CHO cells to fibrinogen stimulated the activation of
JNK, a known downstream effector of Rac [16], and JNK
activation and lamellipodia formation were inhibited by
dominant-negative RacN17. We propose that αIIbβ3 and
Syk act in concert to activate Rac, in part by stimulating
tyrosine phosphorylation of Vav1, which is known to
increase the Rac exchange activity of the Vav1 Dbl homol-
ogy (DH) domain [10]. An analogous series of events may
take place in platelets given the fact that tyrosine phospho-
rylation of Syk and Vav1 [3,12] and lamellipodial extension
[38] occur soon after cells adhere to fibrinogen. Further-
more, platelet adhesion stimulates actin polymerization
[39], a response that can be triggered directly by addition
of constitutively active Rac to detergent-permeabilized
platelets [40].
Integrin aIIbb3 signaling to PI 3¢-kinase
Expression of Syk and Vav1 in A5 CHO cells was associ-
ated with an adhesion-dependent increase in PI 3′-kinase
activity, as assessed by enzymatic activity of Akt, a
serine/threonine kinase regulated by the lipid products of
PI 3′-kinase [41]. This response was inhibited by wort-
mannin, an irreversible inhibitor of PI 3′-kinase. In
platelets, agonists appear to stimulate at least three PI 
3′-kinase isoforms, generating PI 3,4,5-trisphosphate and
PI 3,4-bisphosphate, leading to two waves of Akt activa-
tion. Since some of these responses require αIIbβ3
engagement [29], we propose that they may also be
dependent on Syk and Vav1.
Of the downstream effectors of Syk and Vav1 studied,
only PI 3′-kinase and lamellipodia formation were inhib-
ited by wortmannin. As the Rac exchange activity of Vav1
is activated when PI 3,4,5-trisphosphate binds to the Vav1
pleckstrin homology (PH) domain [42], wortmannin may
inhibit Rac by preventing generation of this lipid. Wort-
mannin exerted no inhibitory influence on the activation
of JNK, however. As lamellipodia formation and JNK acti-
vation were both inhibited by dominant-negative Rac, it is
likely that both events are regulated by Rac or a closely
related protein. Although it is difficult to reconcile how
these two Rac-regulated events are differentially sensitive
to wortmannin, Rac may be activated by distinct exchange
proteins with different sensitivity to wortmannin or the
wortmannin-sensitive step in lamellipodia formation may
be downstream of Rac.
Integrin aIIbb3 signaling to ERK2
Activation of ERK2 through αIIbβ3 displayed the same
dependence on Syk and Vav1 as did activation of JNK.
Whereas JNK activation was dependent on activation of
Rac, ERK2 activation was dependent on Ras. One estab-
lished means by which integrins can activate ERKs is
through the activation of Src and FAK, resulting in the
tyrosine phosphorylation of binding sites for the SH2
domain of Grb2/Sos and activation of the Ras/Raf pathway
[2,18]. The present results suggest an additional route for
integrin activation of ERK2 in hematopoietic cells that
involves Src, Syk, Vav1 and Ras. For example, Vav1 may
associate with and influence the function of Grb2 and
other components of the ERK pathway [13,20–22].
Integrin aIIbb3 signaling to Cbl
The strong induction of Cbl phosphorylation in adherent
A5 CHO cells expressing Syk and Vav1 adds to the
mounting evidence that Cbl is involved in integrin signal-
ing. Cbl is phosphorylated on tyrosine after stimulation of
integrins [24,26,43], and oncogenic forms of Cbl induce
anchorage-independence in NIH-3T3 cells [26]. In addi-
tion, reduction of Cbl expression in macrophages using
antisense Cbl oligonucleotides inhibits cell spreading on
fibronectin [44]. Like Vav1, Cbl can function as a scaffold
for the assembly of signaling complexes though its multi-
ple protein-binding sites [23]. For example, the associa-
tion of Cbl with the p85 subunit of PI 3′-kinase observed
in the present study and others may be one way to recruit
PI 3′-kinase activity to receptor complexes [24,44]. Here,
the 3′ polyphosphoinositide (3′PPI) products of this
enzyme could regulate the activity of other cellular pro-
teins such as Vav1 and Akt.
Cbl could be phosphorylated by one of several protein
tyrosine kinases activated by integrin engagement. Cbl
has been shown to associate with Src kinases as well as
Syk, and reduction or elimination of the activity of 
Src family enzymes results in reduction in tyrosine
phosphorylation of Cbl [27,45]. As Syk activation is
dependent on Src kinase catalytic activity in adherent A5
CHO cells [5], it is difficult at the present time to distin-
guish which enzyme is responsible for Cbl phosphoryl-
ation in these cells. 
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Integrin aIIbb3 signaling independent of actin
polymerization
Previous studies of Src kinases in integrin signaling have
focused on the role of Src interactions with FAK following
actin polymerization and contractility. Here, we report
that Src enhancement of Syk and Vav1 phosphorylation in
fibrinogen-adherent A5 CHO cells is not inhibited by
cytochalasin D, indicating that Src activation by αIIbβ3 is
not dependent on actin polymerization. Thus, in
hematopoietic cells, Src may be activated by events 
proximal to the integrin tail and then participate either
with Syk to regulate events in lamellipodia or with FAK to
regulate events in focal adhesions. Additionally, Src 
activation by fibronectin integrin receptors was found to
be resistant to cytochalasin D [18].
Unlike integrin-mediated activation of FAK and its down-
stream effectors, αIIbβ3-induced Syk and Vav1 tyrosine
phosphorylation, and Syk- and Vav1-dependent activation
of ERK2, JNK, Akt and Cbl phosphorylation were found
to be insensitive to inhibition of actin polymerization. We
believe that this sensitivity to cytochalasin D is dependent
on Syk and Vav1 expression as, in the absence of Syk and
Vav1, integrin-induced ERK2 activation in A5 CHO cells
is inhibited by cytochalasin D (data not shown). These
results indicate that FAK and Syk are activated by αIIbβ3
through distinct mechanisms that differ in their depen-
dence on actin polymerization and that Syk may regulate
integrin-mediated signaling events through distinct signal-
ing pathways.
Conclusions
We propose that platelets and other hematopoietic cells
have a unique integrin signaling pathway that includes a
Src family kinase, Syk and Vav1 (Figure 9). This pathway
would differ in certain key respects from the ‘classical’
integrin–Src–FAK pathway, most notably by its relative
proximity, both spatially and temporally, to the integrin
and by its ability to promote assembly of an integrin signal-
ing complex that is initially independent of actin polymer-
ization. Indeed, one function of this pathway may be to
promote actin polymerization and cytoskeletal rearrange-
ments through tyrosine phosphorylation of adaptors such as
Vav1 and Cbl and activation of Rac, MAP kinases and PI
3′-kinase. The multiple outputs from this pathway would
be expected to collaborate with other signaling pathways to
effect the full range of anchorage-dependent responses of
platelets and other hematopoietic cells.
Materials and methods
Cell lines, plasmids and transfections
The A5 CHO cell line stably expressing the αIIbβ3 integrin was
described previously [5]. The pEMCV–Myc–Syk and pEMCV–Myc–Syk
K402R constructs were generated by placing a Myc epitope tag at the
5′ end of Syk using PCR. A point mutation in the ATP-binding site of
Syk (K402R) was generated by site-directed mutagenesis. Additional
plasmids were obtained as follows:  pEF–neo–Myc–Vav1 was obtained
from A. Altman; pCAGGS–HA–Cbl was from S. Burakoff;
pCMV–Myc–RacN17 was from M. Simon; pHA–JNK was obtained from
M. Renshaw; pHA–ERK2 was from M. Weber; and pcCMV–HA–Akt
was from P. Tsichlis [46].
For transfections, 2 × 106 cells on 100 mm tissue culture plates were
transfected with 4 µg total DNA using the Lipofectamine reagent
(Gibco). The amount of plasmid DNA for each construct was as
follows: 0.5 µg Syk, 1 µg Vav1, 0.5 µg c-Cbl, 0.2 µg HA–ERK2, 0.5 µg
HA–JNK, 0.02 µg HA–Akt and 0.25 µg RacN17. After transfection
(24 h), cells were serum starved in 0.1% FBS and, 24 h later, used for
adhesion assays.
Adhesion assays
Cells were washed with PBS and trypsinized for 10 min at 37°C. Cells
were harvested in PBS/5 mM EDTA and 1 mg/ml soybean trypsin
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Figure 9
Model for possible protein interactions involved in Syk and Vav1
regulation of integrin-αIIbβ3-mediated signaling based on known
binding interactions of the components. Src and Syk activation by
αIIbβ3 engagement could lead to phosphorylation of Cbl and Vav1.
Cbl can interact with a phosphotyrosine site on Syk through its SH2-
like domain and, in turn, the Vav1 SH2 domain can bind to a
phosphotyrosine site on Cbl. Cbl might also recruit the p85 and
p110 subunits of PI 3′-kinase (PI3K) to the integrin complex. In
addition to activation of Akt, the 3′PPI products of PI 3′-kinase might
interact with the PH domain of tyrosine phosphorylated Vav1,
promoting Rac exchange activity. ERK2 activation might result from
the interaction of Grb2 with the SH3 domain of Vav1. Vav1
localization in lamellipodia may be stabilized by interaction with talin
and vinculin as those proteins have been shown to be constitutively
associated with Vav1 in T cells [49]. CH, calponin homology domain;
PTK, protein tyrosine kinase.
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inhibitor, washed once and resuspended in DMEM. Cells were incu-
bated in suspension for 40 min at 37°C prior to replating. When indi-
cated, cytochalasin D (10 µM) was added to cells 40 min prior to
plating and wortmannin (100 nM) 15 min prior to plating. Cells were
placed in 100 mm fibrinogen-coated plates (100 µg/ml) and allowed to
adhere for 15–45 min. Suspension cells were held in a small volume of
DMEM or placed in BSA-coated plates. Non-adherent cells were
removed from fibrinogen-coated plates and adherent cells were lysed
in 500 µl lysis buffer. Suspension cells were either lysed in an equal
volume of 2× lysis buffer, or were collected from the BSA plates, pel-
leted and lysed in 500 µl 1× lysis buffer. All extracts were clarified by
centrifugation and total protein levels were determined using
Coomassie dye reagent (BioRad) or BCA (Pierce).
Immunoprecipitation and immunoblotting
Syk and Vav1 were immunoprecipitated after lysis in Src kinase lysis
buffer [14] using rabbit anti-Syk antibody generated to the Spacer B
region of Syk, and rabbit anti-Vav1 antibody (Santa Cruz). Cbl was
immunoprecipitated after lysis in Cbl lysis buffer [27] using rabbit-anti-
Cbl antibody (Santa Cruz). Precipitates were collected on protein
A–agarose beads (Pierce) and washed 3× with lysis buffer before solu-
bilizing in 2× SDS sample buffer and separation by SDS–PAGE. Gels
were transferred to PVDF membranes and blocked in 5% BSA. Blots
were probed with anti-phosphotyrosine antibody (4G10, Tom Roberts),
immunoprecipitating antibody or rabbit-anti p85 PI 3′-kinase antibody
(Upstate Biochemical). Blots were probed with HRP-conjugated sec-
ondary antibody (BioRad) and visualized by chemiluminescence (NEN).
Kinase assays
HA-tagged ERK2, Akt and JNK were immunoprecipitated with mouse
anti-HA 12CA5 monoclonal antibody prepared as previously described
[47]. Immunoprecipitates were processed for in vitro kinase assays as
follows: ERK2 using myelin basic protein (Gibco) as a substrate [48];
Akt using histone 2B (Boehringer Mannheim) as a substrate [28]; and
JNK immunoprecipitates using GST–c-Jun (Upstate Biochemical) as a
substrate [16]. After separation by SDS–PAGE, gels were transferred
to PVDF membranes. After exposing blots to film for autoradiography
and to a Fuji phosphoimager for quantitation, blots were blocked and
probed with mouse anti-ERK antibody (Transduction Labs), rabbit anti-
Akt antibody [46] or with rabbit anti-JNK1 antibody (Santa Cruz).
Confocal microscopy
Cells were transfected with GFP alone (pEGFP, 0.02 µg, Clontech) or
with a combination of GFP, Syk and Vav1 as described above; 24 h
later, the cells were plated onto fibrinogen-coated coverslips and incu-
bated an additional 18 h. Then adherent cells were fixed, permeabilized
with Triton X-100 and stained with rhodamine–phalloidin to mark F-
actin. Lamellipodia formation in fibrinogen-adherent cells was quanti-
tated and expressed as the percentage of 100 transfected cells
containing more than one lamellipodium. For Syk colocalization experi-
ments, cells were transfected with Syk and, 24 h later, plated onto fib-
rinogen-coated coverslips for either 15 min or 18 h. After fixation and
permeabilization, cells were double-stained with a polyclonal antibody
to Syk and either rhodamine–phalloidin or a polyclonal antibody to αIIb.
For Vav1 colocalization studies, cells were transfected with Syk (non-
epitope tagged) and Vav1 and plated for 18 h onto fibrinogen-coated
coverslips. After fixation and permeabilization, the cells were double-
stained with an antibody to the Myc tag (Vav1) and an antibody to αIIb.
Cells were analyzed with an MRC 1024 Bio-Rad laser scanning confo-
cal imaging system attached to a Leitz Diaplan microscope.
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